Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Instrumentation Laboratory
Device/Diagnostics Quarterly Deal-Making Statistics, Q1 2017
Medtech companies brought in $2.3 billion in financing in Q1 2017, a slight decrease from Q4 2016; device M&A deals totaled $5.8 billion, a sharp decline from the prior quarter, but there were some billion-dollar deals. Q1 diagnostics financings – totaling $1.2 billion (thanks to a $900 million Series B round by cancer diagnostics company Grail) – showed a significant increase over the preceding quarter, as did the Q1 M&As at $700 million versus the previous $87 million.
FDA Guidance Sought To Fill Anticoagulant IVD Gap
There is a need for assays to help guide therapy with the growing number of anticoagulant drugs on the market, but without clearer FDA guidelines development will be a challenge, companies and labs tell the agency.
With Pluck and Luck, Sysmex Tackles Hematology
Sysmex's break in the US with distribution partner Roche frees it to reap the rewards of building its own brand. It's betting that a best-of-breed strategy can help it double revenues by 2006 and increase margins. It's got a stellar reputation but it's in a tough market that doesn't leave much room for error.
Diagnostic Products Corp.'s Contrarian Bet
DPC has successfully transformed itself from a reagent to a systems company and carved out a niche in immunoassay systems, but has it gone as far as it can on its own in a consolidating industry that favors breadth of product lines across lab segments?
- Diagnostic Equipment & Supplies
In Vitro Diagnostics
- Hematology, Coagulation
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.